Clinical Trial Update: Blood Markers of Early Pancreas Cancer

View source ↗

Summary

A University of Nebraska study is recruiting to identify blood biomarkers for early detection of pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Nebraska | Conditions: Diabetes Mellitus, Type 2, PreDiabetes | Status: RECRUITING